Conditions: Cataract Inflammation
Keywords: Surgery
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 415
Healthy volunteers: no

Brief summary:
This clinical study is being conducted to identify the most effective drug concentration and dose frequency of BOL-303242-X (Mapracorat) ophthalmic suspension, for the treatment of inflammation following cataract surgery.

Detailed description:

Arms:
arm 1: BOL-303242-X (Mapracorat) arm 2: Vehicle for BOL-303242-X (Mapracorat)

Interventions: intervention 1: BOL-303242-X intervention 2: Vehicle for BOL-303242-X
Intervention descriptions: intervention 1: Medication instilled into the study eye, subjects randomized to various drug concentrations and dose schedules. intervention 2: Medication instilled into the study eye, subjects randomized to various drug dose schedules.

Protocol document: